Global X Genomics & Biotechnology ETF
Save
About
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Biggest holdings
Health care
8.04%
Health care
5.16%
Health care
4.94%
Health care
4.84%
Health care
4.71%
Health care
3.97%
Health care
3.96%
Health care
3.83%
Health care
3.72%
Similar securities
Based on sector and market capitalization
Report issue